Taliser R Avery
Affiliation: Harvard Medical School and Harvard Pilgrim Health Care
- Near real-time adverse drug reaction surveillance within population-based health networks: methodology considerations for data accrualTaliser R Avery
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
Pharmacoepidemiol Drug Saf 22:488-95. 2013..This study describes practical considerations for implementation of near real-time medical product safety surveillance in a distributed health data network...
- Inclusion of 30-day postdischarge detection triples the incidence of hospital-onset methicillin-resistant Staphylococcus aureusTaliser R Avery
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts 02215, USA
Infect Control Hosp Epidemiol 33:114-21. 2012..Hospitalized patients are at increased risk for acquisition of methicillin-resistant Staphylococcus aureus (MRSA). As hospital length of stay shortens, hospital-acquired MRSA events may be more likely to be detected after discharge...
- Drug safety data mining with a tree-based scan statisticMartin Kulldorff
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, USA
Pharmacoepidemiol Drug Saf 22:517-23. 2013..This methodological paper evaluates the tree-based scan statistic data mining method to enhance drug safety surveillance...
- Patient sharing and population genetic structure of methicillin-resistant Staphylococcus aureusWeixiong Ke
Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
Proc Natl Acad Sci U S A 109:6763-8. 2012..These findings suggest that concerted efforts among hospitals that share large numbers of patients may be synergistic to prevent MRSA transmission...